Oregon Grape
A rare case among herbal remedies: real, repeated topical psoriasis trial data
Oregon Grape (Mahonia aquifolium, also classified as Berberis aquifolium) is a berberine-containing shrub native to the Pacific Northwest, long used in traditional herbal medicine for skin conditions and as a general antimicrobial. It shares its key active alkaloid, berberine, with goldenseal — but unlike a lot of traditional botanicals riding on reputation alone, Oregon Grape has a genuinely unusual amount of modern clinical research behind one specific use case: topical treatment of psoriasis.
Multiple trials, including a large open multicentre study and separate double-blind, placebo-controlled trials, have found topical Mahonia aquifolium cream reduces psoriasis severity scores meaningfully over about 12 weeks — a level of clinical evidence that's genuinely rare for an herbal skin remedy. It's also increasingly promoted as a more sustainable alternative to goldenseal, since wild goldenseal populations have faced significant over-harvesting pressure.
Topical Psoriasis Support
A large open multicentre trial of 433 patients found modified PASI scores dropped significantly from 5.5 to 2.3 over 12 weeks of topical use.
Confirmed in Placebo-Controlled Trials
Separate double-blind, placebo-controlled studies have also found benefit for mild-to-moderate psoriasis, strengthening the open-label results.
No Hormonal Side Effects
Unlike topical corticosteroids, Mahonia aquifolium cream doesn't carry the hormonal side-effect profile associated with long-term steroid use.
A More Sustainable Berberine Source
Cultivated more easily than wild goldenseal, making it a lower-impact source of similar alkaloid compounds.
- For psoriasis specifically, this ingredient's evidence is topical — a cream or ointment, not an oral capsule
- Give it the full 12 weeks before judging results — the positive trials measured change over that full period
- Mild skin irritation at the application site is the most commonly reported side effect in trials
- If considering it for other traditional uses (internal, antimicrobial), the modern research base is much thinner than for topical psoriasis use
An open, prospective multicentre trial conducted across 89 dermatological practices in Germany treated 433 patients with subacute and chronic psoriasis using 10% Mahonia aquifolium cream for 12 weeks; modified PASI scores fell significantly from 5.5 to 2.3, with 81.1% of patients rated improved or healed by their dermatologists. A separate review of three additional clinical trials, including double-blind, placebo-controlled data, corroborated benefit for mild-to-moderate plaque psoriasis with a favorable safety profile.
How Oregon Grape Compares
| Ingredient | Best For | Key Difference |
|---|---|---|
| Oregon Grape | Topical Psoriasis Support | Multiple positive clinical trials, more sustainable than goldenseal |
| Goldenseal | Short-Term Antimicrobial Use | Shares berberine content, but different studied use case |
| Berberine | Blood Sugar & Cholesterol Support | Purified, oral use for a completely different application |
| Cat's Claw | Traditional Antimicrobial Use | A different plant with its own distinct traditional use profile |
These are the most common comparisons our customers ask about in-store.
1. Gieler, U., von der Weth, A., & Heger, M. (1995). Mahonia aquifolium: a new type of topical treatment for psoriasis. Journal of Dermatological Treatment, 6(1), 31–34.
2. Gulliver, W.P., & Donsky, H.J. (2005). A report on three recent clinical trials using Mahonia aquifolium 10% topical cream and a review of the worldwide clinical experience with Mahonia aquifolium for the treatment of plaque psoriasis. American Journal of Therapeutics, 12(5), 398–406.
All references are peer-reviewed studies or position stands from reputable organizations.
Related Ingredients
Get Your Free Supplement Guide
“50 Supplement Myths Debunked” PDF + weekly evidence-based tips. 100% free.
Get Your Free PDF →No spam, ever. Unsubscribe anytime.